Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
EXEL
$51.24
+1.24%
EXEL · Exelixis, Inc.
$51.24
+0.63 (+1.24%)
At close · Aug 14
Market Cap
$12.70B
Shares
247.78M
All earnings calls
Earnings call · FY2027 Q2
Exelixis Q2 2026 Financial Results Conference Call
Exelixis Q2 2026 Financial Results Conference Call
Forward guidance
6 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 5, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Total revenues
table
fiscal year 2026
|
$2.5B – $2.55B | — | |
|
Net product revenues
table
fiscal year 2026
|
$2.3B – $2.35B | — | |
|
Research and development expenses
table
fiscal year 2026
|
$825M – $875M | — | |
|
Cost of goods sold, % of net product revenues
table
fiscal year 2026
|
3.5% – 4.5% | — | |
|
Selling, general and administrative expenses
table
fiscal year 2026
|
$575M – $625M | — | |
|
Effective tax rate
table
fiscal year 2026
|
21% – 23% | — |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 5, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 5, 2026 · complete as-filed document